Health Highlights: April 12, 2022

New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more
Philadelphia Becomes First US City to Bring Back Mask Mandate: Faced with rising COVID-19 case counts, the city announced Monday that it will reinstate an indoor mask mandate next week. Read more
Study Finds Just One Dose of HPV Vaccine May be Enough: A single shot provided as much protection against cervical cancer as the standard three-dose regimen, a finding that researchers say could be a game-changer in efforts to vaccinate more people against the human papillomavirus. Read more
Could Some Rheumatoid Arthritis Meds Help Lower Alzheimer's Risk? Preliminary findings suggest a class of rheumatoid arthritis drugs known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients who also suffer from heart disease. Read more
Related Posts
5.9 Percent of Adults Live in Families Experiencing Food Insecurity
THURSDAY, April 20, 2023 (HealthDay News) -- In 2021, 5.9 percent of adults...
Do Fasting Diets Work? Study Finds Meal Size, Not Timing, Key to Weight Loss
WEDNESDAY, Jan. 18, 2023 (HealthDay News) -- When it comes to weight loss, what...
Multifaceted Intervention Cuts Antibiotic Prescribing for UTI
WEDNESDAY, April 12, 2023 (HealthDay News) -- For frail older adults, a...